Isoflurane Terminated Phase 3 Trials for Therapeutic Agent Toxicity / Hydrocephaly Prevention

IndicationsStatusPurposePhase
TerminatedPrevention3
clinicaltrials.gov IdentifierTitleDrugs
NCT02512809Isoflurane-induced Neuroinflammation in Children With Hydrocephalus